Warby Parker (WRBY) Capital Expenditures (2020 - 2026)
Warby Parker's (WRBY) quarterly Capital Expenditures came in at $7.1 million in Q1 2026, down 55.89% YoY from $16.2 million in Q1 2025, and down 89.0% on a QoQ basis from $64.8 million in Q4 2025.
Warby Parker (WRBY) Capital Expenditures (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Capital Expenditures data on file, last reported at $7.1 million in Q1 2026.
- Quarterly Capital Expenditures fell 55.89% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.0 million (up 845.72% YoY) and the FY2025 annual result came in at $67.0 million, up 1416.92% from the prior year.
- Capital Expenditures retreated to $7.1 million in Q1 2026, from $64.8 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $64.8 million in Q4 2025 to a low of -$36.5 million in Q4 2023.
- A 5-year average of $8.4 million and a median of $12.4 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 356.43% — and 2025, when it jumped 5815.45%.
- Tracing WRBY's Capital Expenditures over 5 years: stood at $14.2 million in 2022, then plunged by 356.43% to -$36.5 million in 2023, then jumped by 96.89% to -$1.1 million in 2024, then jumped by 5815.45% to $64.8 million in 2025, then sank by 89.0% to $7.1 million in 2026.
- The last three Capital Expenditures figures came in at $7.1 million (Q1 2026), $64.8 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 22.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.86 Mn |
| Jun 30, 2026 | 22.86 Mn |
| Mar 31, 2026 | 7.12 Mn |
| Mar 31, 2026 | 7.12 Mn |
| Dec 31, 2025 | 64.76 Mn |
| Dec 31, 2025 | 64.76 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -11.51 Mn |
| Jun 30, 2025 | -11.51 Mn |
| Mar 31, 2025 | 16.15 Mn |
| Mar 31, 2025 | 16.15 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | -10.35 Mn |
| Jun 30, 2024 | -10.35 Mn |
| Mar 31, 2024 | 14.44 Mn |
| Mar 31, 2024 | 14.44 Mn |